| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |